Patients with local recurrent disease on PSMA PET/CT had biochemical progression in 16% of cases (10/61 patients), compared to 46/241 patients (19%) of patients with a negative for cancer PSMA PET/CT (p = 0.6). The gene discussed is FOLH1; the disease is cancer.